Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21).
about
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.Ebp1 sumoylation, regulated by TLS/FUS E3 ligase, is required for its anti-proliferative activity.Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements.Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas.Induction of a secreted protein by the myxoid liposarcoma oncogeneHSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer.Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway.Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution.
P2860
Q24533281-E97B7E5D-C85D-4E80-BA35-D2FA87F54588Q30493247-53CCD82D-7385-4D78-AE12-1BB67064FEEAQ33747747-DDD88FEF-2376-4795-8EC0-2FA44090CC2FQ33960227-43F86434-8BAA-48CB-967B-3A476A5977CBQ34566943-6446D37B-B29F-415E-B9FE-356CB375339AQ35088118-A24BF6BB-7C9A-4EFB-B03C-AEEE0509ECB0Q35869259-4DD47EF7-8C96-47CA-AE18-F0652B0288B9Q36336254-91BF0293-9B5B-49A8-BFE3-6252ED2297BFQ36729440-971470A4-0F78-4329-9EF8-97DE75E7CA3BQ36972125-C2AB5835-95A7-4A66-B382-7AE1A4AA26BEQ37694523-8943A432-796D-42DE-8AF8-E0344E49C3EEQ39454928-51FF9DFF-2358-4208-8DE0-035B5C2E3879Q55427534-CCE17434-B5FE-482E-8E6C-6967CEB1925D
P2860
Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21).
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Two distinct FUS breakpoint cl ...... emia with the translocations t
@nl
Two distinct FUS breakpoint cl ...... cations t(12;16) and t(16;21).
@ast
Two distinct FUS breakpoint cl ...... cations t(12;16) and t(16;21).
@en
type
label
Two distinct FUS breakpoint cl ...... emia with the translocations t
@nl
Two distinct FUS breakpoint cl ...... cations t(12;16) and t(16;21).
@ast
Two distinct FUS breakpoint cl ...... cations t(12;16) and t(16;21).
@en
prefLabel
Two distinct FUS breakpoint cl ...... emia with the translocations t
@nl
Two distinct FUS breakpoint cl ...... cations t(12;16) and t(16;21).
@ast
Two distinct FUS breakpoint cl ...... cations t(12;16) and t(16;21).
@en
P1433
P1476
Two distinct FUS breakpoint cl ...... cations t(12;16) and t(16;21).
@en
P2093
P304
P407
P577
1995-09-01T00:00:00Z